drugset / Trial / NCT01500161

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

NCT01500161

Phase 2 Terminated 1 enrolled Texas Oncology Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the multi-lineage hematopoietic chimerism for unrelated umbilical cord blood (UCB) grafts pooled from two to three cord blood units. Also to evaluate the toxicity, and antitumor responses of pooled unrelated UCB transplants.

Timeline

Start
2011-11
Primary completion
2013-11
Completion
2013-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule 3.2 mg/kg Intravenous
Subject Clofarabine Other / unclassified 40 mg/m2 Intravenous
Subject Cytarabine Small molecule 100 mg/m2
Subject Etoposide Small molecule 300 mg/m2 Intravenous
Subject Fludarabine Small molecule 30 mg/kg Intravenous
Subject Melphalan Small molecule 140 mg/m2 Intravenous
Subject carmustine Small molecule 300 mg/m2 Intravenous